1. OAR@UM
  2. External Research Collection
  3. Medicine
  4. Pharmacy and Materia Medica
  5. Journal of the Malta College of Pharmacy Practice
  6. 2011
  7. JMCPP, Issue 17
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/14129
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2016-11-21T10:47:27Z-
dc.date.available2016-11-21T10:47:27Z-
dc.date.issued2011-
dc.identifier.citationPost-Licensing Directorate (2011). Towards the use of safer medicines : why is it important to support the national pharmacovigilance system? Journal of the Malta College of Pharmacy Practice, 17, 11-15.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/14129-
dc.description.abstractAll medicinal products carry an inevitable and unpredictable potential for harm that cannot always be detected at the pre-authorisation stage. Pharmacovigilance comprises the science and activities relating to the assessment, understanding and prevention of adverse effects of medicines The main underlying component of all pharmacovigilance activities is the reporting of Adverse Drug Reactions. With the new directive 2010/84/EC (amending 2001/83/EC) on the community code for medicinal products in the EU it is important that healthcare professionals are refreshed on the need to support pharmacovigilance systems in order to maximise efforts to maintain the safest and most effective medicines on the market.en_GB
dc.language.isoenen_GB
dc.publisherMalta College of Pharmacy Practiceen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectPharmaceutical services -- Malta -- Law and legislationen_GB
dc.subjectDrugs -- Side effectsen_GB
dc.subjectMedication errors -- Maltaen_GB
dc.subjectPharmaceutical policy -- Maltaen_GB
dc.titleTowards the use of safer medicines : why is it important to support the national pharmacovigilance system?en_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.contributor.corpauthorPost-Licensing Directorateen_GB
dc.description.reviewedpeer-revieweden_GB
Appears in Collections:JMCPP, Issue 17
JMCPP, Issue 17

Files in This Item:
File Description SizeFormat 
2011-17-2.pdfTowards the use of safer medicines : why is it important to support the national pharmacovigilance system?73.91 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.